Most U.S. patients face a manufacturer list price near $1,086 per month for branded tirzepatide pens, but realistic out-of-pocket costs vary widely depending on insurance status, indication, and which savings program you use. Commercially insured patients who qualify for Eli Lilly’s copay card can pay greatly reduced amounts per 28-day supply. Cash-paying patients who go through LillyDirect’s self-pay vial program can access brand tirzepatide at lower tiered prices depending on dose. Without either option, retail cash prices typically align near the list price range for branded pens.
Your immediate next step: log into your insurance portal and search your formulary for “tirzepatide” or “Zepbound,” then call the member services number on your card and ask specifically whether your diagnosis (weight management vs. type 2 diabetes) qualifies for coverage. That one call will tell you more about your real monthly cost than any price list.
Price snapshots:
Your four-step action checklist:
The single biggest variable in what you pay is not the milligram strength of your dose. It’s the route you use to access the medication.
Tirzepatide comes in auto-injector pens (four pens per 28-day supply for most doses) and, through LillyDirect, as single-dose vials. Pen packs carry higher list prices because they’re the standard retail format. Vials require reconstitution before injection, which adds a step, but the price difference can be substantial. A patient titrating from 2.5 mg to 10 mg over several months will see their LillyDirect vial cost move from $299 to $499 as the dose increases.
Mounjaro and Zepbound contain the same molecule. Mounjaro is FDA-approved for type 2 diabetes; Zepbound is approved for chronic weight management. That distinction matters enormously for insurance. Employer-sponsored formularies are highly variable: a plan that covers Mounjaro for diabetes may explicitly exclude Zepbound for weight loss, leaving patients with a full cash-pay bill even when they have otherwise solid coverage.
Your pharmacy benefit manager (PBM) negotiates the contracted rate your insurer pays, which determines your copay tier. The same prescription can cost $50 at one pharmacy and $150 at another depending on which PBMs are in-network. Retail cash prices at major chains without any coupon typically sit near list. GoodRx and similar coupon marketplaces can shave off some of that, but they rarely beat manufacturer vial programs or copay-card outcomes.
Pro Tip: The access route — insurance plus a savings card, LillyDirect self-pay vials, or a telehealth bundle — is usually a larger cost driver than your dose strength. Nail down the route before you worry about the milligram.
Without insurance, you have three realistic options: retail cash price, LillyDirect self-pay vials, or a telehealth-bundled program. The spread between them is wide.
At major pharmacy chains without a coupon, branded tirzepatide pens run close to list price, roughly $1,000–$1,300 per month depending on dose and pharmacy. GoodRx coupons typically bring pen pricing down to $900–$1,100 at major chains — a real discount, but still far above what manufacturer programs offer.
LillyDirect is Eli Lilly’s direct-to-patient pharmacy program. It offers brand Zepbound in single-dose vials at tiered pricing by dose:
| Format | Dose | LillyDirect self-pay price (per 28-day supply) | Retail list price (pen) |
|---|---|---|---|
| Single-dose vial | 2.5 mg | $299 | $499–$1,086 |
| Single-dose vial | 5 mg | $399 | $499–$1,086 |
| Single-dose vial | — | $449 | $499–$1,086 |
| Single-dose vial | 10 mg and above | $499+ | $499–$1,086 |
These prices require a valid prescription and adherence to LillyDirect’s refill timing rules. Some promotional terms require refills within 45 days to retain the lower price tier, and program terms are subject to change (some current terms expire December 31, 2026). Always verify current pricing directly at pricinginfo.lilly.com/zepbound before committing.
Vials require reconstitution, meaning you draw the medication into a syringe before injecting rather than using a pre-filled auto-injector pen. If you’re new to self-injection, FitRx publishes a step-by-step tirzepatide injection guide that walks through the process clearly.
During the period when tirzepatide was on the FDA shortage list, compounding pharmacies could legally produce copies of the drug, and many telehealth clinics offered these at prices well below brand. That window has largely closed. The FDA’s enforcement discretion for compounding ended in 2025, and the national GLP-1 supply began stabilizing. Most of the very low-priced compounded options are no longer widely available, and the regulatory environment makes new compounded programs riskier for both pharmacies and patients.
Scenario examples:
Insurance can make tirzepatide genuinely affordable or leave you with a bill close to list price. The outcome depends on three things: your plan’s formulary, your diagnosis, and whether you qualify for a manufacturer savings card.
Insurers place drugs on tiers within their formulary. A Tier 1 drug might cost $10–$30 per fill; a Tier 3 or Tier 4 specialty drug can mean 20–30% coinsurance on a $1,000+ list price. Tirzepatide typically lands on a higher tier when it’s covered at all. Prior authorization is almost universal for this drug class, meaning your prescriber must submit documentation before your insurer will approve coverage.
Step therapy requirements are common too. Many plans require patients to try and fail one or more other medications (often metformin for diabetes, or an older weight-loss drug for obesity) before approving tirzepatide. That process can add weeks to your timeline.
Lilly’s savings programs can reduce copays for eligible commercially insured patients to as low as $25 per 28-day supply, subject to monthly and annual caps. This is the single best financial outcome available to commercially insured patients. The catch: you must have commercial insurance that covers the drug, and you cannot be enrolled in Medicare, Medicaid, or any other federal or state government health program.
Statistic callout: Commercially insured patients using Lilly’s copay card can pay greatly reduced copays per 28-day supply for Zepbound compared to list price. Annual caps apply, and eligibility rules are strict.
Medicare Part D coverage for tirzepatide depends on indication. Mounjaro (for type 2 diabetes) has broader coverage under Part D than Zepbound (for weight management), which has historically faced more exclusions. The CMS Medicare GLP-1 bridge program has expanded some access, but coverage for weight-loss-only indications under Medicare remains more restricted than for diabetes. Check cms.gov for current program details. Medicaid coverage varies by state.
Before you fill a prescription, gather these details. The 10 minutes it takes can save hundreds of dollars.
Information to collect:
When you call your insurer, ask:
Pro Tip: Ask your pharmacist to run a “test claim” before you commit to a fill. They can see your exact out-of-pocket cost under your plan without you paying anything. This takes about two minutes and gives you the real number.
Once you have your per-fill copay, divide by 28 and multiply by 30 to convert to a monthly budget figure. If your plan covers 30-day supplies, the math is direct. If it covers 28-day supplies (four pens), your monthly cost is essentially the per-fill copay, since most patients fill once every four weeks.
Pro Tip: Use GoodRx’s price-check tool to get a cash-price baseline at pharmacies near you. Even if you plan to use insurance, knowing the cash price tells you whether your insurance is actually saving you money on this drug.
Here are the five most effective options, ranked by expected savings and ease of access.
Best for: commercially insured patients whose plan covers tirzepatide.
Potential monthly cost: greatly reduced copays per 28-day supply. Enroll at zepbound.lilly.com before your first fill. Bring the card (digital or physical) to the pharmacy at pickup. Annual caps apply, and the card cannot be used with Medicare or Medicaid.
Best for: uninsured patients or those whose insurance doesn’t cover tirzepatide.
Potential monthly cost: $299–$499 depending on dose. Requires a prescription, adherence to refill timing rules, and comfort with vial reconstitution. LillyDirect’s pricing tiers are published and updated; always verify before ordering. This route does not include a clinician fee — you’ll need a separate prescriber.
Best for: patients who need pens and can’t access the above programs.
GoodRx and similar tools can reduce pen pricing to roughly $900–$1,100 at major chains. That’s still expensive, but it’s a real reduction from list. Independent pharmacies sometimes offer better cash prices than chains — worth a call.
Lilly’s patient assistance program (Lilly Cares) may cover medication costs for patients who meet income eligibility thresholds and lack adequate insurance. Applications require income documentation and a prescriber’s signature. Processing takes several weeks, so apply early.
Some telehealth platforms bundle the clinician consultation, prescription management, and medication fulfillment into a single monthly fee. The key question to ask before signing up: is the quoted price all-in (medication + clinician + shipping) or just the medication line item? A $299/month telehealth quote that excludes the drug cost is not the same as a $299/month all-in bundle.
| Route | Typical monthly cost | What’s included | Coverage likelihood | Key caveat |
|---|---|---|---|---|
| Insurance + copay card | $25–$150 | Drug only | High (if formulary covers) | Requires commercial insurance; prior auth likely |
| LillyDirect self-pay vials | $299–$499 | Drug only | N/A (self-pay) | Refill timing rules; vial reconstitution required |
| Retail cash (GoodRx) | $900–$1,100 | Drug only | N/A | Highest cost; no clinician included |
| Telehealth bundle | $299–$499 | Drug + clinician + shipping (varies) | N/A | Verify all-in vs. drug-only pricing |
| Patient assistance | $0–low | Drug only | Income-based | Weeks-long application; income limits apply |
Pro Tip: When comparing a telehealth bundle to LillyDirect, add up every line: drug cost + clinician visit fee + shipping + any monthly membership. That’s your true monthly cost. A bundle that looks more expensive than LillyDirect vials may actually be cheaper once you factor in the prescriber visit you’d otherwise pay for separately.
Pro Tip: LillyDirect’s promotional pricing has timing rules. If you miss a refill window (some programs require refills within 45 days), you may lose the promotional rate and pay a higher price for that fill. Set a calendar reminder for your refill date.
Pro Tip: Manufacturer savings card terms change annually. Some current Lilly savings card terms expire December 31, 2026. Re-verify your card’s terms at the start of each calendar year.
Denials are common for tirzepatide, especially for weight-management indications. They are not always final.
Timeline to expect: Initial PA decisions typically take 3–15 business days. Internal appeals can take 30–60 days. External reviews add additional time. Budget 4–10 weeks from first submission to final decision if you encounter multiple denial rounds.
Telehealth programs for tirzepatide bundle services that you’d otherwise pay for separately: the prescriber consultation, prescription management, portal messaging, and sometimes shipping. Understanding what’s bundled and what’s billed separately is the only way to compare programs accurately.
Add these line items together:
| Cost component | LillyDirect self-pay (vials) | Typical telehealth bundle | Retail cash (pens) |
|---|---|---|---|
| Drug cost/month | $299–$499 | Varies (often included) | $900–$1,300 |
| Clinician fee | Not included | Often included | Not included |
| Shipping | Not included | Often included | Not included |
| Membership fee | None | — | None |
| Estimated all-in | $299–$499 + prescriber cost | — | $900–$1,300+ |
FitRx bundles online clinician review, prescription fulfillment, and portal support into its weight-loss program, so you’re not piecing together a prescriber visit, a pharmacy order, and a shipping arrangement separately. That bundled structure makes it straightforward to calculate your actual monthly spend before you commit.
Pro Tip: Before signing up for any telehealth program, ask one direct question: “Is the medication cost included in the monthly fee, or is it billed separately?” The answer changes the math entirely.
If you’re considering or currently using compounded tirzepatide, there are regulatory and safety factors worth understanding clearly.
The FDA placed tirzepatide on its drug shortage list, which temporarily allowed compounding pharmacies to produce copies of the drug. The FDA has since clarified its policies as the national GLP-1 supply began stabilizing, narrowing the window for compounded versions. Patients who relied on compounded tirzepatide from telehealth clinics during the shortage period may find those programs discontinued, repriced, or operating in a more restricted regulatory environment.
One-sentence guidance: always confirm that a licensed prescriber is actively supervising your treatment and that the pharmacy can provide documentation of its testing practices before you inject anything.
Tirzepatide’s list price near $1,086/month is not what most patients actually pay — your real cost depends almost entirely on your insurance status, indication, and which savings route you use.
| Point | Details |
|---|---|
| List price vs. real cost | Branded pen list price runs $499–$1,086.37 per 28-day fill; most patients pay far less with savings programs. |
| LillyDirect vials | Self-pay vials start at $299/month (2.5 mg) and are the lowest-cost regulated option for uninsured patients. |
| Copay card savings | Commercially insured patients with Lilly’s savings card can pay as little as $25 per 28-day supply. |
| Indication determines coverage | Diabetes (Mounjaro) and weight management (Zepbound) often have different formulary coverage; verify your diagnosis code before filling. |
| FitRx bundled option | FitRx bundles clinician review, prescription fulfillment, and portal support so you can calculate your true all-in monthly cost upfront. |
Tirzepatide pricing is genuinely confusing, and most of the confusion is structural. The same molecule carries two brand names, two FDA indications, and wildly different coverage outcomes depending on your insurer, your diagnosis code, and which pharmacy you use. A patient with commercial insurance and a copay card can pay $25/month. A patient without coverage at the same pharmacy pays $1,086.37. That gap is not a rounding error.
FitRx built this guide because patients deserve a clear picture of what they’ll actually pay before they start treatment, not after their first surprise bill. The telehealth model FitRx uses — bundling the clinician consultation, prescription management, and medication fulfillment — exists specifically to remove the guesswork from that calculation. When you know the all-in monthly cost before you enroll, you can make a real financial decision.
If you’re weighing LillyDirect vials against a telehealth bundle, the math is straightforward: add up every line item (drug + prescriber + shipping + membership), compare the totals, and pick the route that fits your budget and your preference for clinical support. FitRx’s weight-loss program page lays out what’s included so you can do that comparison directly.
The biggest frustration patients report with tirzepatide isn’t the injection — it’s getting a drug price quote that turns out to be just the medication, with the prescriber visit, labs, and shipping billed separately. FitRx is built differently. The FitRx weight-loss program bundles your online clinician consultation, prescription fulfillment, and ongoing portal support into a single, transparent structure — so you know what you’re paying before you commit, not after your first fill.
What FitRx includes:
No hunting for a separate prescriber. No surprise shipping charges. Check whether you’re eligible and see FitRx’s current pricing in under two minutes.
Pricing for tirzepatide changes frequently. Always verify figures directly with the primary source before making a financial decision. The prices in this article reflect publicly available data as of early 2026.
Pricing last verified: early 2026. Manufacturer program terms, copay-card caps, and LillyDirect promotional pricing are subject to change. Confirm current figures directly with the source before filling a prescription.
This article is general information, not medical or financial advice. Confirm your coverage, eligibility, and treatment plan with a licensed healthcare provider and your insurance plan directly.
.svg)
